Post-Election Decompression: Where Do We Go from Here?

Conclusion While it is still too soon to be sure how the election will affect the industry, what is sure is that Pharma stocks immediately benefitted from the election results. Short-term success does not confirm that the gains will continue, but as of November 9, 2016, the NYSE Arca Biotechnology Index jumped 8.9%, Allergan shares rose 8%, Celgene Corp. rose 8.6%, and Pfizer Inc. rose 7%. Drug wholesalers and other industry middlemen also got a boost, with McKesson up 6.4% and Express Scripts up 3.4%. With a fully-Republican federal government, it is possible that we finally see the stalemate in Washington break. However, with great power comes great responsibility, and the ability of the Republican-led government to govern will be tested over the next two years and has the potential to result in major legislative reforms being implemented during this period, circa 2008-2010, when Democrats controlled the executive and legislative branches.       Related StoriesWyden Releases Report on Dangers of Underfunding Opioid AbuseRepresentative Lieu Laser-Focused on Device Act, OlympusHouse Ways and Means Subcommittee on Oversight Holds Hearing on Health Care Fraud Investigations 
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs